Sykes to head $250 million Deepbridge fund that "feeds its own children"
This article was originally published in Scrip
Executive Summary
Sir Richard Sykes, former chairman and CEO of GlaxoSmithKline, is to head a new investment fund targeting early-stage life sciences, eco-innovation and software enterprises. He has been appointed chair of Deepbridge Innovation Fund (DBIF), a new fund set up by the international asset management group SL Investment Management and the early-stage corporate advisory firm Deepbridge Capital, based in Chester UK.